Table 1. Baseline characteristics and follow-up data of 581 patients with tuberculosis, Rwanda, 2007.
| N (%) or median (IQR) | |
| A - Baseline characteristics | |
| 1. Demographic factors | |
| Sex | |
| Male | 359 (61.8) |
| Female | 222 (38.2) |
| Age (years) | |
| Median age (IQR) | 31 (25–41) |
| 15–24 | 145 (25.0) |
| 25–34 | 199 (34.3) |
| 35–44 | 126 (21.7) |
| ≥45 | 111 (19.1) |
| Occupation | |
| Low-income group* | 193 (33.2) |
| Students | 44 (7.6) |
| Prisoners | 23 (4.0) |
| Employed | 105 (18.1) |
| Missing | 216 (37.2) |
| 2. Clinical factors | |
| Type of TB | |
| PTB scanty or 1+ | 109 (18.8) |
| PTB 2+ | 109 (18.8) |
| PTB 3+ | 93 (16.0) |
| PTB smear neg | 64 (11.0) |
| PTB “microscopy not-done” | 34 (5.9) |
| Extra-pulmonary TB | 164 (28.2) |
| Missing | 8 (1.4) |
| HIV | |
| Negative | 327 (56.3) |
| Positive | 242 (41.7) |
| Missing | 12 (2.1) |
| Weight (kgs) | |
| Median weight (IQR) | 51 (45–58) |
| ≤48 | 208 (35.8) |
| 49–55 | 177 (30.5) |
| ≥56 | 175 (30.1) |
| Missing | 21 (3.6) |
| 3. Treatment centre factors | |
| Location of health facility | |
| Rural | 68 (11.7) |
| Urban | 513 (88.3) |
| District | |
| Burera | 13 (2.2) |
| Gakenke | 24 (4.1) |
| Gasabo | 143 (24.6) |
| Gicumbi | 26 (4.5) |
| Kicukiro | 104 (17.9) |
| Musanze | 58 (10.0) |
| Ngororero | 17 (2.9) |
| Nyarugenge | 196 (33.7) |
| B. Follow-up data | |
| Adherence | |
| Took ≥90% of doses | 480 (82.6%) |
| Took <90% of doses | 56 (9.6%) |
| No data | 45 (7.8%) |
| Repeat C2 sputum smear status ** | |
| Negative sputum smear | 226 (72.7%) |
| Positive sputum smear | 52 (16.7%) |
| No sputum smear result | 33 (10.6%) |
| Antiretroviral treatment | |
| Not HIV infected | 327 (56.3%) |
| HIV infected, on ART at time of start TB R/ | 73 (12.6%) |
| HIV infected, started ART within 3 mo of start TB R/ | 37 (6.4%) |
| HIV infected, not on ART or started >3 mo after start of TB R/ | 132 (22.7%) |
| HIV status unknown, no ART | 12 (2.1%) |
| Use of co-trimoxazole prophylaxis | |
| Not HIV infected | 327 (56.3%) |
| HIV infected, on co-trimoxazole at time of start TB R/ | 107 (18.4%) |
| HIV infected, started co-trimoxazole within 3 mo of start TB R/ | 48 (8.3%) |
| HIV infected, not on co-trimoxazole or started >3 mo after start of TB R/ | 87 (15.0%) |
| HIV status unknown, no co-trimoxazole | 12 (2.1%) |
| Outcome | |
| Cured | 236 (40.6%) |
| Treatment completed | 221 (38.0%) |
| Treatment failure | 15 (2.6%) |
| Died | 69 (11.9%) |
| Defaulted | 13 (2.2%) |
| Transfer out | 20 (3.4%) |
| Outcome not recorded | 7 (1.2%) |
Abbreviations: ART antiretroviral treatment; TB Tuberculosis; PTB pulmonary TB; IQR inter-quartile range; HIV Human Immunodeficiency Virus; kg kilogram.
*
Farming, housewives, unemployed, laborer, vendor;
**
smear status 2 months after start of TB treatment (for details see text); percentages based on those with smear positive PTB at baseline.